Fundz

Crio Inc. reported raising $2 Million in an initial SEC Form D filing, from an offering of $2 Million

PRIVATEMar 03, 2021

Amount Raised

$2 Million

$2 Million sold, per SEC Form D (first sale Mar 3, 2021)

Round Type

Seed

BostonOtherHealthcareCommerce And ShoppingHealth Care

Quick answer

Crio Inc. raised $2 Million in a Seed round, dated March 3, 2021. Crio Inc. is based in Boston, Massachusetts, United States.

How much did Crio Inc. raise?
Crio Inc. raised $2 Million in a Seed round on March 3, 2021.
What does Crio Inc. do?
CRIO, the leader in eSource technology, is an enterprise grade eClinical solution transforming clinical research.
Where is Crio Inc. based and how big is it?
Crio Inc. is based in Boston, Massachusetts, United States.
Who are the decision-makers at Crio Inc?
Fundz holds 1 contact at Crio Inc., including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Commerce And Shopping around the same time

Companies in the same sectors as Crio Inc. that raised within 45 days of this round, from Fundz verified event records.

  • pulseData, Inc. raised $17M on April 16, 2021.
  • Predictably Human raised $1.7M (Seed) on April 15, 2021.
  • Medable Inc. raised $78M (Funding Round) on April 15, 2021.
  • Ocelot Bio raised $36M on April 15, 2021.
  • Zenflow raised $24M on April 15, 2021.
  • Pathway Health raised $2.4M (Seed) on April 14, 2021.

Who to call at Crio Inc., and when

A new round usually means Crio Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Crio Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Crio Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Crio Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Crio Inc.

Location

177 Huntington Avenue, Ste 1703

Boston, Massachusetts, United States

About

CRIO, the leader in eSource technology, is an enterprise grade eClinical solution transforming clinical research. Research sites, academic research centers, pharmaceutical and biotechnology companies are able to streamline workflows with a system that enables a single point of data capture. CRIO’s mission is to design and deliver a modern, intuitive, and integrated software platform that reimagines clinical trials for quality, speed, and patient-centricity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Crio Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsBrook W., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Crio Inc.'s next move

See what Strategic adds

Crio Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.